Takeda Pharmaceutical Company L (TAK)

Healthcare

$18.73

+1.13%

nightly snapshot · 10/11/2026

ALPHASCORE™ · C+ · Watch

ALPHASCORE

56

/ 100

C+

WATCH

▲ 0 · 30D

KEY FUNDAMENTALS

ROE-2.3%

NET MARGIN-3.4%

GROSS MARGIN65.1%

MKT CAP$59.83B

loading full analysis…

DAILY BRIEF

Takeda Pharmaceutical Company L features an AlphaScore of 56/100 in the Healthcare sector as of October 11, 2026. Fundamentals include a high gross margin of 65.12% and a dividend yield of 3.33%. A major strength is its strong gross margin, showcasing solid core product profitability. A key risk is its negative net margin of -3.38% and negative return on equity of -2.26%. Evidence is limited to the supplied dataset.

Written 11/10/2026, 00:43:41 UTC · Snapshot 11/10/2026